A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
The purpose of this study is to examine the safety of Ipilimumab and patterns of use in the treatment of unresectable or metastatic melanoma in the post-approval setting
Time Perspective: this study does have a retrospective component involving a subset of patients
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.
Inclusion Criteria:
Exclusion Criteria:
CABA, 1426, Argentina
CABA, C1417DNT, Argentina
CABA, C1426ANZ, Argentina
Rosario- Santa Fe, S2000KZE, Argentina
Tweeds Head, New South Wales 02485, Australia
Haint Saint Paul, 7100, Belgium
Clermont Ferrand Cédex 1, 63003, France
Grenoble Cédex, 38043, France
Nouvelle Caledonie, 98849, France
Dessau-Roblau, 06847, Germany
Neas Efkarpia, Thessaloniki 56429, Greece
Mezourlo, 41334, Greece
Wilton, CORK T12 DC4A, Ireland
Santiago de Compostela; A Coruña, 15706, Spain
Oxfordshire, OX3 7LE, United Kingdom
Staffordshire, ST46QG, United Kingdom